Cat hair, bacteria found at Novo Nordisk plant during inspection, STAT reports

Cat hair, pests, bacteria, and equipment failures were among the concerns of a recent regulatory inspection of a manufacturing facility that Novo Nordisk (NVO) bought last year as part of its parent company’s acquisition of Catalent, STAT’s Ed Silverman and Elaine Chen report. The plant, which was one of three that Novo acquired late last year, conducts a variety of tasks, from filling vials and syringes with medicines to labeling and packaging.